Market Forecast By By Types (Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Actinium-225 (Ac-225), Others), By By Application (Oncology, Cardiology, Thyroid, Neurology, Others) And Competitive Landscape
| Product Code: ETC200115 | Publication Date: Jun 2023 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 |
The Mexico Nuclear Medicine Radioisotopes Market was estimated at USD 228 Million in 2025 and is projected to reach USD 265 Million by 2032, growing at a CAGR of 2.2% from 2026 to 2032. This growth is significantly influenced by an increasing prevalence of chronic diseases, such as cancer and cardiovascular conditions, which necessitate advanced diagnostic and therapeutic modalities. Additionally, the growing adoption of nuclear medicine technologies and enhanced awareness among healthcare professionals about the benefits of using radiopharmaceuticals are driving this market's expansion.
The Mexico Nuclear Medicine Radioisotopes market has shown a promising recovery following a contraction of 4.0% in 2021, largely due to pandemic-related disruptions. In 2022, the market rebounded impressively, recording a growth of 6.3%, driven by an uptick in healthcare investments and increasing consumer demand for diagnostic imaging. Stable growth has continued into 2023, with a forecasted rate of 4.5%, supported by advancements in technology and expanding infrastructure. While the growth rate is expected to gradually moderate, with projections of 3.9% in 2024 and 2.4% in 2025, ongoing investments in digital health technologies and policy support for nuclear medicine are set to sustain interest in this sector through 2032 and beyond.
This graph highlights how the Mexico Nuclear Medicine Radioisotopes Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -4.0% | decreased healthcare infrastructure investments |
| 2022 | 6.3% | growing demand for diagnostic imaging |
| 2023 | 4.5% | increased funding for research initiatives |
| 2024 | 3.9% | expansion of healthcare facilities nationwide |
| 2025 | 2.4% | rising prevalence of chronic diseases |
| 2026 | 0.9% | enhancements in imaging technology adoption |
| 2027 | 2.7% | growing public awareness of health |
| 2028 | 2.7% | increased collaborations with private sector |
| 2029 | 2.8% | growing regional consumption patterns |
| 2030 | 2.8% | rising number of accredited clinics |
| 2031 | 2.5% | growing partnerships with international firms |
| 2032 | 3.1% | increased government health program investments |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
In Mexico, the demand for high-quality radioisotopes is surging as healthcare providers seek effective diagnostic solutions. The utilization of radioisotopes in targeted cancer therapies is particularly noteworthy, with professionals recognizing their potential to improve patient outcomes significantly.
This market is characterized by a competitive landscape where multiple entities are consistently enhancing their production capabilities. The focus remains on ensuring the availability of safe and reliable radiopharmaceuticals, a critical aspect as patient safety remains paramount in nuclear medicine procedures.
While the market is on an upward trajectory, it faces several restraints. One significant challenge is the limited availability of isotopes due to the reliance on specific production facilities, which can lead to supply chain vulnerabilities. Additionally, there is a need for more specialized training for medical personnel to handle nuclear materials safely, which may hinder the adoption of nuclear medicine practices. Regulatory hurdles concerning the safety and transport of radioactive materials further complicate market expansion.
Emerging trends in the Mexico Nuclear Medicine Radioisotopes Market indicate a shift towards personalized medicine, leveraging radiopharmaceuticals tailored to individual patient profiles. Additionally, the integration of artificial intelligence in imaging and diagnostic procedures is gaining traction, further enhancing the precision of nuclear medicine applications. Furthermore, there is a growing trend towards collaborating between research institutions and healthcare facilities to innovate and improve therapeutic options.
The Mexico Nuclear Medicine Radioisotopes Market presents numerous growth opportunities, particularly in expanding access to advanced radiopharmaceuticals. Investments in infrastructure to support isotope production and distribution can significantly enhance market capabilities. Moreover, partnerships with international organizations for knowledge transfer and technology sharing are likely to accelerate advancements in nuclear medicine techniques.
Government initiatives play a crucial role in promoting the Mexico Nuclear Medicine Radioisotopes Market. Policies that support research funding and technological advancements are essential for market growth. Additionally, public health programs emphasizing early detection and treatment of chronic diseases highlight the importance of nuclear medicine, encouraging further investment and infrastructure development within the sector.
Looking ahead to the period between 2026 and 2032, the Mexico Nuclear Medicine Radioisotopes Market is expected to experience robust growth. Advances in technology and production capabilities will likely improve the efficiency and safety of radioisotope use. As healthcare systems increasingly recognize the value of nuclear medicine, particularly in oncology and cardiology, the market will continue to thrive, enhancing patient care and outcomes.
Recent developments in the Mexico Nuclear Medicine Radioisotopes Market have highlighted innovations in production methods and the introduction of new radiopharmaceuticals aimed at improving diagnostic accuracy. Collaborations between medical institutions and research centers have strengthened capabilities, while regulatory advancements have facilitated smoother pathways for the introduction of novel isotopes into the market. Efforts to increase public awareness about the benefits of nuclear medicine are also underway, further bolstering market growth.
|
1 Executive Summary |
|
2 Introduction |
|
2.1 Key Highlights of the Report |
|
2.2 Report Description |
|
2.3 Market Scope & Segmentation |
|
2.4 Research Methodology |
|
2.5 Assumptions |
|
3 Mexico Nuclear Medicine Radioisotopes Market Overview |
|
3.1 Mexico Country Macro Economic Indicators |
|
3.2 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, 2022 & 2032F |
|
3.3 Mexico Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
|
3.4 Mexico Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
|
3.5 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Types, 2022 & 2032F |
|
3.6 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Application, 2022 & 2032F |
|
4 Mexico Nuclear Medicine Radioisotopes Market Dynamics |
|
4.1 Impact Analysis |
|
4.2 Market Drivers |
|
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine diagnostics and treatment |
|
4.2.2 Technological advancements in nuclear medicine imaging techniques |
|
4.2.3 Growing investments in healthcare infrastructure in Mexico |
|
4.3 Market Restraints |
|
4.3.1 High cost associated with nuclear medicine procedures |
|
4.3.2 Stringent regulatory requirements for the use of radioisotopes in medical applications |
|
5 Mexico Nuclear Medicine Radioisotopes Market Trends |
|
6 Mexico Nuclear Medicine Radioisotopes Market, By Types |
|
6.1 Mexico Nuclear Medicine Radioisotopes Market, By By Types |
|
6.1.1 Overview and Analysis |
|
6.1.2 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By By Types, 2022-2032F |
|
6.1.3 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2022-2032F |
|
6.1.4 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2022-2032F |
|
6.1.5 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2022-2032F |
|
6.1.6 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2022-2032F |
|
6.1.7 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2022-2032F |
|
6.1.8 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2022-2032F |
|
6.1.9 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
|
6.1.10 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
|
6.2 Mexico Nuclear Medicine Radioisotopes Market, By By Application |
|
6.2.1 Overview and Analysis |
|
6.2.2 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2022-2032F |
|
6.2.3 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2022-2032F |
|
6.2.4 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2022-2032F |
|
6.2.5 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2022-2032F |
|
6.2.6 Mexico Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2022-2032F |
|
7 Mexico Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
|
7.1 Mexico Nuclear Medicine Radioisotopes Market Export to Major Countries |
|
7.2 Mexico Nuclear Medicine Radioisotopes Market Imports from Major Countries |
|
8 Mexico Nuclear Medicine Radioisotopes Market Key Performance Indicators |
| 8.1 Patient adoption rate of nuclear medicine procedures |
| 8.2 Number of nuclear medicine facilities in Mexico utilizing radioisotopes |
| 8.3 Research and development investments in nuclear medicine technologies |
|
9 Mexico Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
|
9.1 Mexico Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Types, 2022 & 2032F |
|
9.2 Mexico Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Application, 2022 & 2032F |
|
10 Mexico Nuclear Medicine Radioisotopes Market - Competitive Landscape |
|
10.1 Mexico Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2025 |
|
10.2 Mexico Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
|
11 Company Profiles |
|
12 Recommendations |
|
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here